Disc Medicine, Inc. (IRON)
NASDAQ:IRON
Want to see IRON full AI Analyst Report?
Total Valuation
Disc Medicine has a market cap or net worth of $2.56B. The enterprise value is $2.51B.
Market Cap$2.56B
Enterprise Value$2.51B
Share Statistics
Disc Medicine has 38,199,090 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding38,199,090
Owned by Insiders9.35%
Owned by Institutions12.87%
Financial Efficiency
Disc Medicine’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -30.62%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-30.62%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee0.00
Profits Per Employee-2.26M
Employee Count94
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Disc Medicine is ―. Disc Medicine’s PEG ratio is -0.26.
PE Ratio―
PS Ratio0.00
PB Ratio3.79
Price to Fair Value3.79
Price to FCF-15.46
Price to Operating Cash Flow-12.84
PEG Ratio-0.26
Income Statement
In the last 12 months, Disc Medicine had revenue of 0.00 and earned -212.18M in profits. Earnings per share was -6.01.
Revenue0.00
Gross Profit0.00
Operating Income-236.02M
Pretax Income-211.82M
Net Income-212.18M
EBITDA-207.94M
Earnings Per Share (EPS)-6.01
Cash Flow
In the last 12 months, operating cash flow was -201.25M and capital expenditures -82.00K, giving a free cash flow of -201.34M billion.
Operating Cash Flow-201.25M
Free Cash Flow-201.34M
Free Cash Flow per Share-5.27
Dividends & Yields
Disc Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.68
52-Week Price Change39.74%
50-Day Moving Average65.79
200-Day Moving Average72.25
Relative Strength Index (RSI)49.08
Average Volume (3m)438.84K
Important Dates
Disc Medicine upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Disc Medicine as a current ratio of 21.94, with Debt / Equity ratio of 4.51%
Current Ratio21.94
Quick Ratio21.94
Debt to Market Cap<0.01
Net Debt to EBITDA0.43
Interest Coverage Ratio-65.43
Taxes
In the past 12 months, Disc Medicine has paid 361.00K in taxes.
Income Tax361.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Disc Medicine EV to EBITDA ratio is -13.05, with an EV/FCF ratio of -14.97.
EV to Sales0.00
EV to EBITDA-13.05
EV to Free Cash Flow-14.97
EV to Operating Cash Flow-15.04
Balance Sheet
Disc Medicine has $730.16M in cash and marketable securities with $31.06M in debt, giving a net cash position of $699.10M billion.
Cash & Marketable Securities$730.16M
Total Debt$31.06M
Net Cash$699.10M
Net Cash Per Share$18.30
Tangible Book Value Per Share$20.96
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Disc Medicine is $98.22, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$98.22
Price Target Upside36.86% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast―
EPS Growth Forecast-68.57%